2017
DOI: 10.1016/j.jpba.2017.03.063
|View full text |Cite
|
Sign up to set email alerts
|

Application of 2D-NMR with room temperature NMR probes for the assessment of the higher order structure of filgrastim

Abstract: The higher order structure (HOS) of biotherapeutics is a critical quality attribute that can be evaluated by nuclear magnetic resonance (NMR) spectroscopy at atomic resolution. NMR spectral mapping of HOS can be used to establish HOS consistency of a biologic across manufacturing changes or to compare a biosimilar to an innovator reference product. A previous inter-laboratory study performed using filgrastim drug products demonstrated that two-dimensional (2D)-NMR 1HN-15NH heteronuclear correlation spectroscop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 17 publications
0
17
0
Order By: Relevance
“…Indeed, a previous NMR interlaboratory study on the small protein therapeutic filgrastim, displayed a slight clustering of spectra by instrument, although, experimental parameters and instrument performance were not carefully matched in this study. 18,19 Sample conditions must also be carefully considered. Because signals from formulation components can be orders of magnitude greater than those from the protein, even minor differences in formulation conditions may lead to bias in the PCA results.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Indeed, a previous NMR interlaboratory study on the small protein therapeutic filgrastim, displayed a slight clustering of spectra by instrument, although, experimental parameters and instrument performance were not carefully matched in this study. 18,19 Sample conditions must also be carefully considered. Because signals from formulation components can be orders of magnitude greater than those from the protein, even minor differences in formulation conditions may lead to bias in the PCA results.…”
Section: Resultsmentioning
confidence: 99%
“…Indeed a number of 1D 1 H NMR based methods have been recently proposed for chemometric HOS analysis of mAbs. ,, The application of chemometric approaches to the problem of 2D spectral analysis of protein therapeutics is less well established but is actively being explored. Proposed approaches include direct point-to-point linear correlation analysis of the processed data matrix, spectral covariance analysis, multivariate principal component analysis both on the processed data matrix , and on tables of peak positions and intensities, spectral distance metrics such as nearest neighbor approaches on peak tables, and total spectral Euclidian deviation …”
mentioning
confidence: 99%
“…However, PEGylation is a challenge for structural biologist: (1) It inhibits the crystallization of the protein [30], (2) causes serious problems to the standard structural biology techniques [31,32,33,34,35], and (3) limits the use of solution NMR to the small proteins because it significantly increases the hydrodynamic volume of the protein itself [30,36,37,38,39]. Therefore, it is not possible to obtain information at the atomic level to drive any possible structure-based optimization processes using only a single biophysical method.…”
Section: The Importance Of Integrated Structural Biologymentioning
confidence: 99%
“…[1][2][3] Therefore, the process of defining and controlling product critical quality attributes (CQA), which are defined by the quality by design approach (QbD), [4][5][6] is crucial, and ensures that the safety and efficacy of the product are maintained. 7 The higher order structure (HOS) of a product, which may be considered a CQA, can be studied by a wide range of techniques, such as fluorescence detection, 8 circular dichroism, [9][10][11][12][13] X-ray crystallography, [14][15][16] nuclear magnetic resonance (NMR), [17][18][19] epitope detection and Fourier-transform infrared spectroscopy. [20][21][22][23] This characterization approach is in line with the U.S. Food and Drug Administration's Quality by design (QbD) initiative 24 linking a desired product quality with physico-chemical or biological properties/characteristics.…”
Section: Introductionmentioning
confidence: 99%
“…The study allowed differentiation between different products. 19 A significant disadvantage of existing HOS analysis techniques is their lack of applicability within a routine quality control (QC) environment. The techniques require expensive equipment, highly trained operators, complex post-acquisition treatment of data and software that would comply with the data integrity requirements prescribed in cGMP.…”
Section: Introductionmentioning
confidence: 99%